Anti-Ma2 Antibody-Associated Paraneoplastic Neurological Syndromes: A Pilot Study.

Area of Science:

• Neurology
• Immunology
• Oncology

Background:

• Paraneoplastic neurologic syndromes (PNSs) are immune-mediated disorders triggered by cancer.
• Anti-Ma2 antibody is a key biomarker for diagnosing specific PNS cases.
• Sensorimotor neuropathy (SMN) is a common presentation in some PNS subtypes.

Purpose of the Study:

• To report and explore characteristics of anti-Ma2 antibody-associated paraneoplastic neurologic syndrome (Ma2-PNS).
• To investigate the frequent association of Ma2-PNS with sensorimotor neuropathy (SMN).
• To evaluate the utility of factor analysis of mixed data (FAMD) in analyzing Ma2-PNS patient data.

Main Methods:

• Retrospective review of clinical data from eight patients with confirmed Ma2-PNS.
• Application of factor analysis of mixed data (FAMD) for comprehensive data visualization and analysis.
• Utilized R software for statistical analysis and visualization.

Main Results:

• The cohort showed a female predominance (5/8).
• Sensorimotor neuropathy (SMN) was the most frequent presentation (4/8), followed by limbic encephalitis (LE) (3/8).
• Associated cancers included testicular germ-cell tumor, thymoma, and multiple myeloma (MM) presenting with chronic SMN.

Conclusions:

• Ma2-PNS frequently impacts the peripheral nervous system.
• Multiple myeloma (MM) is identified as a potential associated cancer presenting with chronic SMN.
• Factor analysis of mixed data (FAMD) demonstrates potential as a valuable clinical tool for understanding Ma2-PNS.